These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 20851016)

  • 1. Absence of consistent association between human leukocyte antigen-I and -II alleles and human T-lymphotropic virus type 1 (HTLV-1)-associated myelopathy/tropical spastic paraparesis risk in an HTLV-1 French Afro-Caribbean population.
    Deschamps R; Béra O; Belrose G; Lezin A; Bellance R; Signate A; Cabre P; Smadja D; Césaire R; Olindo S
    Int J Infect Dis; 2010 Nov; 14(11):e986-90. PubMed ID: 20851016
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polygenic control of human T lymphotropic virus type I (HTLV-I) provirus load and the risk of HTLV-I-associated myelopathy/tropical spastic paraparesis.
    Vine AM; Witkover AD; Lloyd AL; Jeffery KJ; Siddiqui A; Marshall SE; Bunce M; Eiraku N; Izumo S; Usuku K; Osame M; Bangham CR
    J Infect Dis; 2002 Oct; 186(7):932-9. PubMed ID: 12232833
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Possible implication of NFKB1A and NKG2D genes in susceptibility to HTLV-1-associated myelopathy/tropical spastic paraparesis in Peruvian patients infected with HTLV-1.
    Talledo M; López G; Huyghe JR; Verdonck K; González E; Clark D; Vanham G; Gotuzzo E; Van Camp G; Van Laer L
    J Med Virol; 2012 Feb; 84(2):319-26. PubMed ID: 22170554
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between HLA-DRB1*01 and HLA-Cw*08 and outcome following HTLV-I infection.
    Rafatpanah H; Pravica V; Faridhosseini R; Tabatabaei A; Ollier W; Poulton K; Thomson W; Hutchinson I
    Iran J Immunol; 2007 Jun; 4(2):94-100. PubMed ID: 17652849
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polymorphism in the interleukin-10 promoter affects both provirus load and the risk of human T lymphotropic virus type I-associated myelopathy/tropical spastic paraparesis.
    Sabouri AH; Saito M; Lloyd AL; Vine AM; Witkover AW; Furukawa Y; Izumo S; Arimura K; Marshall SE; Usuku K; Bangham CR; Osame M
    J Infect Dis; 2004 Oct; 190(7):1279-85. PubMed ID: 15346339
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of killer cell immunoglobulin-like receptor gene content and human leukocyte antigen-C group in susceptibility to human T-lymphotropic virus 1-associated myelopathy/tropical spastic paraparesis in Peru.
    Talledo M; López G; Huyghe JR; Verdonck K; González E; Clark D; Senitzer D; Vanham G; Gotuzzo E; Van Camp G; Van Laer L
    Hum Immunol; 2010 Aug; 71(8):804-8. PubMed ID: 20483367
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum concentration and genetic polymorphism in the 5'-untraslated region of VEGF is not associated with susceptibility to HTLV-I associated myelopathy/tropical spastic paraparesis (HAM/TSP) in HTLV-I infected individuals.
    Saito M; Usuku K; Nobuhara Y; Matsumoto W; Kodama D; Sabouri AH; Izumo S; Arimura K; Osame M
    J Neurol Sci; 2004 Apr; 219(1-2):157-61. PubMed ID: 15050452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased activated human T cell lymphotropic virus type I (HTLV-I) Tax11-19-specific memory and effector CD8+ cells in patients with HTLV-I-associated myelopathy/tropical spastic paraparesis: correlation with HTLV-I provirus load.
    Nagai M; Kubota R; Greten TF; Schneck JP; Leist TP; Jacobson S
    J Infect Dis; 2001 Jan; 183(2):197-205. PubMed ID: 11120926
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The influence of HLA class I alleles and heterozygosity on the outcome of human T cell lymphotropic virus type I infection.
    Jeffery KJ; Siddiqui AA; Bunce M; Lloyd AL; Vine AM; Witkover AD; Izumo S; Usuku K; Welsh KI; Osame M; Bangham CR
    J Immunol; 2000 Dec; 165(12):7278-84. PubMed ID: 11120862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Infective dermatitis and human T cell lymphotropic virus type 1-associated myelopathy/tropical spastic paraparesis in childhood and adolescence.
    Primo JR; Brites C; Oliveira Mde F; Moreno-Carvalho O; Machado M; Bittencourt AL
    Clin Infect Dis; 2005 Aug; 41(4):535-41. PubMed ID: 16028164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ApaI polymorphism of vitamin D receptor gene is associated with susceptibility to HTLV-1-associated myelopathy/tropical spastic paraparesis in HTLV-1 infected individuals.
    Saito M; Eiraku N; Usuku K; Nobuhara Y; Matsumoto W; Kodama D; Sabouri AH; Izumo S; Arimura K; Osame M
    J Neurol Sci; 2005 May; 232(1-2):29-35. PubMed ID: 15850579
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of host genetic and viral factors as surrogate markers for HTLV-1-associated myelopathy/tropical spastic paraparesis in Peruvian HTLV-1-infected patients.
    Talledo M; López G; Huyghe JR; Verdonck K; Adaui V; González E; Best I; Clark D; Vanham G; Gotuzzo E; Van Camp G; Van Laer L
    J Med Virol; 2010 Mar; 82(3):460-6. PubMed ID: 20087941
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HLA-B*35 as a new marker for susceptibility to human T-cell lymphotropic virus type 1 (HTLV-1) Associated Myelopathy/Tropical Spastic Paraparesis (HAM/TSP) in patients living in Argentina.
    Benencio P; Fraile Gonzalez SA; Ducasa N; Page K; Berini CA; Biglione MM
    Retrovirology; 2020 Sep; 17(1):29. PubMed ID: 32883310
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Longer dinucleotide repeat polymorphism in matrix metalloproteinase-9 (MMP-9) gene promoter which correlates with higher HTLV-I Tax mediated transcriptional activity influences the risk of HTLV-I associated myelopathy/tropical spastic paraparesis (HAM/TSP).
    Kodama D; Saito M; Matsumoto W; Sabouri AH; Izumo S; Arimura K; Usuku K; Bangham CR; Osame M
    J Neuroimmunol; 2004 Nov; 156(1-2):188-94. PubMed ID: 15465610
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Temporal dynamics of human T-lymphotropic virus type I tax mRNA and proviral DNA load in peripheral blood mononuclear cells of human T-lymphotropic virus type I-associated myelopathy patients.
    Ramirez E; Cartier L; Torres M; Barria M
    J Med Virol; 2007 Jun; 79(6):782-90. PubMed ID: 17457906
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ex vivo analysis of human T lymphotropic virus type 1-specific CD4+ cells by use of a major histocompatibility complex class II tetramer composed of a neurological disease-susceptibility allele and its immunodominant peptide.
    Nose H; Kubota R; Seth NP; Goon PK; Tanaka Y; Izumo S; Usuku K; Ohara Y; Wucherpfennig KW; Bangham CR; Osame M; Saito M
    J Infect Dis; 2007 Dec; 196(12):1761-72. PubMed ID: 18190256
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased human T lymphotropic virus type I (HTLV-I) provirus load and alteration in T cell phenotype after interferon-alpha therapy for HTLV-I-associated myelopathy/tropical spastic paraparesis.
    Saito M; Nakagawa M; Kaseda S; Matsuzaki T; Jonosono M; Eiraku N; Kubota R; Takenouchi N; Nagai M; Furukawa Y; Usuku K; Izumo S; Osame M
    J Infect Dis; 2004 Jan; 189(1):29-40. PubMed ID: 14702150
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Different cytokine production in tax-expressing cells between patients with human T cell lymphotropic virus type I (HTLV-I)-associated myelopathy/tropical spastic paraparesis and asymptomatic HTLV-I carriers.
    Furukawa Y; Saito M; Matsumoto W; Usuku K; Tanaka Y; Izumo S; Osame M
    J Infect Dis; 2003 Apr; 187(7):1116-25. PubMed ID: 12660926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical symptoms and the odds of human T-cell lymphotropic virus type 1-associated myelopathy/ tropical spastic paraparesis (HAM/TSP) in healthy virus carriers: application of best-fit logistic regression equation based on host genotype, age, and provirus load.
    Nose H; Saito M; Usuku K; Sabouri AH; Matsuzaki T; Kubota R; Eiraku N; Furukawa Y; Izumo S; Arimura K; Osame M
    J Neurovirol; 2006 Jun; 12(3):171-7. PubMed ID: 16877298
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tropical spastic paraparesis/human T leukemia virus type 1-associated myelopathy in HIV type 1-coinfected patients.
    Beilke MA; Japa S; Moeller-Hadi C; Martin-Schild S
    Clin Infect Dis; 2005 Sep; 41(6):e57-63. PubMed ID: 16107970
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.